Breast Cancer Treatment: How CDK4/6 Inhibitors Work (monarchE & NATALEE Trials) ASBrS 4 Mins Read What Are CDK4/6 Inhibitors? CDK4/6 inhibitors, such as abemaciclib and ribociclib, are changing breast cancer treatment for HR+/HER2- early-stage patients.…
SLIDES: FDA Approves Kisqali / Ribociclib for Early High-Risk Breast Cancer Breast Cancer 2 Mins Read The FDA has recently approved Kisqali (ribociclib) in combination with a non-steroidal aromatase inhibitor (NSAI) for the treatment of early-stage…
